Jazz’s Midphase Tremor Drug Misses Mark, Future Uncertain by Lilu Anderson 20.06.2024 Jazz Pharmaceuticals hits a hurdle as its essential tremor drug trial misses primary endpoint. Awaiting Parkinson's trial results for future ...
John Cox Becomes CEO at Dyne Therapeutics by Mark Eisenberg 29.03.2024 Dyne Therapeutics appoints new CEO, George Eliades, and other key executives as it prepares for growth. Robert Coffin to step ...